HIV/AIDS Skepticism

53c5db81627a583e1bbf Pointing to evidence that HIV is not the necessary and sufficient cause of AIDS

Author Archive

Antiretrovirals kill: Official data, peer-reviewed journal

Posted by Henry Bauer on 2015/08/10

(updated with full article)

HIV+ people in hospital who were on anti-retrovirals were more likely to die of non-AIDS conditions than HIV+ people NOT being treated with ARVs. The deaths were owing to known “side” effects of ARVs: cardiovascular, liver, various infections.

That is reported in the paper drawn to my attention by a comment from lukas. Note that the data covers a period of 16 years beginning with the introduction of “life-saving HAART cocktails” in the mid-1990s:

Cowell et al., TRENDS IN HOSPITAL DEATHS AMONG HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS DURING THE ANTIRETROVIRAL THERAPY ERA, 1995 TO 2011,
Journal of Hospital Medicine, 30 June 2015 doi: 10.1002/jhm.2409. [Epub ahead of print]

Here is the full paper, courtesy of David Rasnick:

Cowell 2015 copy

And here is just the abstract:

RESULTS:
In-hospital deaths declined significantly from 1995 to 2011 (P < 0.0001); those attributable to non-AIDS increased (43% to 70.5%, P < 0.0001). Non-AIDS deaths were most commonly caused by non-AIDS infection (20.3%), cardiovascular (11.3%) and liver disease (8.5%), and non-AIDS malignancy (7.8%). Patients with non-AIDS compared to AIDS-related deaths were older (median age 48 vs 40 years, P < 0.0001), more likely to be on ART (74.1% vs 55.8%, P = 0.0001), less likely to have a CD4 count of <200 cells/mm3 (47.2% vs 97.1%, P < 0.0001), and more likely to have an HIV viral load of ≤400 copies/mL (38.1% vs 4.1%, P < 0.0001). Non-AIDS deaths were associated with 4.5 and 4.2 times greater likelihood of comorbid underlying liver and cardiovascular disease, respectively.
CONCLUSIONS:
Non-AIDS deaths increased significantly during the ART era and are now the most common cause of in-hospital deaths; non-AIDS infection, cardiovascular and liver disease, and malignancies were major contributors to mortality. Higher CD4 cell count, liver, and cardiovascular comorbidities were most strongly associated with non-AIDS deaths. Interventions targeting non-AIDS-associated conditions are needed to reduce inpatient mortality among HIV-infected patients. Journal of Hospital Medicine 2015. © 2015 Society of Hospital Medicine.
© 2015 Society of Hospital Medicine.

This journal is not held by our library, and I’m waiting for Interlibrary Loan to get me a copy. IN the meantime, the abstract’s details given above seem to tell the story clearly enough.

 

Posted in antiretroviral drugs, HIV risk groups, HIV/AIDS numbers | Tagged: | 12 Comments »

HIV/AIDS history and facts

Posted by Henry Bauer on 2015/08/08

Cardiac surgeon  Donald W. Miller has written a wonderfully comprehensive yet concise analysis of the genesis of HIV/AIDS and of the actual facts:

“HIV/AIDS: Unmasking Medical Falsehood…”. 
https://www.lewrockwell.com/2015/08/donald-w-miller-jr-md/unmasking-medical-falsehood/

It illustrates the feeling of alienation, of being relatively sane in an insane world, that I get periodically:

Who looks at evidence? Almost no one
http://wp.me/p2VG42-5L

 

Posted in antiretroviral drugs, consensus, experts, Funds for HIV/AIDS, global warming, HIV absurdities, HIV does not cause AIDS, HIV risk groups, HIV skepticism, HIV tests, HIV/AIDS numbers, Legal aspects, sexual transmission, unwarranted dogmatism in science, vaccines | Tagged: , , | 4 Comments »

Spam e-mail from a discredited source

Posted by Henry Bauer on 2015/07/18

This morning’s e-mail greeted me with this:

Murtagh spam

 

I don’t think I had ever corresponded with Murtagh, but the name was familiar: the Office of Medical & Scientific Justice has had dealings with him:
“he committed perjury, manipulated evidence, withheld discovery documents, and breached a settlement agreement with Emory University by impersonating Emory officials and sending defamatory emails
. . . .
Because of Murtagh’s notorious and ongoing behavior, OMSJ provides support to the website JamesMurtaghMDtruth.com, which tracks lawsuits and will post public court documents filed on his behalf.”

I’m posting this on the presumption that many other people received this spam and may not be aware of Murtagh’s character (although the “causes” listed at the bottom of his e-mail do offer some clues).

* * * * * * * *

The “Good news!” promised in the e-mail is the attached description of the conference of the International AIDS Society in Vancouver. One doesn’t know whether to laugh or cry at the talking points, for example:
“UN Secretary General Ban Ki-moon announced that the goal of having 15 million HIV-positive people on antiretroviral therapy by the end of 2015 — the so-called 15 by 15 strategy — had been achieved in March, nine months early.”
Not everyone would agree that bringing toxic medication to healthy people is necessarily always a good thing.

The chief goal now is a world free of AIDS by 2030. This too has to be sold by a snappy slogan like “15 by 15”, this time “the 90-90-90 milestone”: “90 per cent of people aware of their HIV status, 90 per cent of those infected on antiretroviral therapy, and 90 per cent of those being treated showing undetectable viral loads”.
That milestone would need to be met five years from now to make the world free in 2030.

One can only marvel at the knowledge and understanding that allows such accurate predictions decades ahead. But then Bill Gates, who surely knows almost everything about computers and therefore projections, also told us not so long ago that there would be an HIV vaccine in 15 years from now. The IAS Conference blurb does mention vaccine: The 2030 goal is only
“the virtual elimination of the AIDS pandemic. We’re not talking about eradicating HIV — HIV will remain a low-level endemic condition going forward and we will need a vaccine and we will need a cure”.
So HIV/AIDS researchers and administrators can rest assured that even when 2030 arrives, there will still be jobs and research funds for them. In the meantime, drug companies can look forward to ever-increasing revenues from antiretroviral drugs.

 

Posted in antiretroviral drugs, experts, HIV absurdities, HIV skepticism, HIV/AIDS numbers, uncritical media, vaccines | Tagged: , , , | 2 Comments »

Climate–change beliefs are politically and not scientifically determined

Posted by Henry Bauer on 2015/05/09

This was posted here by mistake, intended for my scimedskeptic.blog, and has now been removed here. If you are interested in the climate-change controversy, which has striking similarities with HIV/AIDS, by all means have a look there.

 

Posted in consensus, global warming, scientific literacy, unwarranted dogmatism in science | Tagged: , | 13 Comments »

Elsevier strikes again: Predator or merely parasite?

Posted by Henry Bauer on 2015/05/04

According to the doubtfully reliable Wikipedia, “Elsevier B.V. . . . is an academic publishing company that publishes medical and scientific literature. It is a part of the Reed Elsevier group” which is “an Anglo-Dutch multinational publishing and information company co-headquartered in London, United Kingdom and Amsterdam, Netherlands. It operates in the science, medical, legal, risk, marketing, financial, and business sectors”.

Actually, Elsevier is strictly in the business of making money, not of providing information, and its activities have included MISinforming or DISinforming, as illustrated by these actions:

⇒ Elsevier put out a number of medical-company advertisements masquerading as professional medical journals — “Elsevier published 6 fake journals”; “Merck published fake journal”.

⇒ Elsevier took over and soon destroyed Medical Hypotheses, after having withdrawn an article that corrected a published error: It was claimed that there had been 300,00 AIDS deaths per year in South Africa, whereas the official count was reported by Statistics South Africa as about 15,000 — “Censored by Elsevier”; “Public Health Service of Italy accepts work of Ruggiero et al.”; Chapter 3 in Dogmatism in Science and Medicine: How Dominant Theories Monopolize Research and Stifle the Search for Truth (McFarland 2012).

⇒ Now Elsevier is in the process of doing its destructive work on the Medical Journal of Australia: “Editor of Medical Journal of Australia fired after criticizing decision to outsource to Elsevier”.

The decision-makers at the company that controls the Medical Journal of Australia do not understand — as the Journal’s now-fired editor does —that the such “technical” matters as the procedures by which articles are submitted, the “infrastructure”, is inseparable from editorial matters. It determines how the Journal presents itself to prospective authors.
My own experience of publishing in an Elsevier journal can best be described as intense frustration at unnecessary complications: creating accounts, navigating ambiguous web pages, filling out numerous forms, putting up with inept computerese — all these only because Elsevier is so anxious to make profits, charging exorbitantly for reprints and requiring authors to pledge not to make copies of their own work available freely to others. Elsevier, not the author of an article, takes the copyright to articles in the journals it publishes. It does not forbid authors from sharing PREprints with the rest of the scientific community, but “Preprints should not be added to or enhanced in any way in order to appear more like, or to substitute for, the final versions of articles”, so that prospective readers will need to access articles via libraries that subscribe — at exorbitant rates — to Elsevier publications, or via reprints supplied to authors at outlandishly exorbitant charges: the article I published runs to 5 pages, and reprints would have cost me $220 for 100 (minimum order), decreasing per copy to $400 for 400 — for the economy version without covers; the deluxe off-prints with covers would have cost $430 for the minimum 100 (but less per copy for more, e.g. “only” $925 for 400). As everyone knows, once something has been printed, there is negligible marginal cost in running off any number of extra copies.

⇒ The exorbitant charges that bring Elsevier extraordinary profit margin led mathematicians to organize a boycott of Elsevier journals: “Why are we boycotting Elsevier?”; “Mathematicians organize boycott of a publisher”; “Scientists sign petition to boycott academic publisher Elsevier”; “Why Elsevier?”;  “The Elsevier boycott one year on”.
In 2010, on revenues of ~$3.2 billion, Elsevier’s profit was 36% (“Why scientists are boycotting a publisher”, Boston Globe, February 2012). Such a profit margin will make jealous even the racketeering Rx-drug industry (Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare by Peter C. Gøtzsche).

⇒ The possibility of cheap online publishing has brought an explosion of hundreds if not thousands of “journals” that librarian Jeffrey Beall has described as “predatory” since they offer nothing but opportunity for anyone to get published in “academic journals” if they can pay for it.
Beall’s survey of predatory publishers lists 693 in 2015, up from 18 in 2011, 23 in 2012, 225 in 2013, and 477 in 2014.
Is Elsevier not also predatory in the same way? It too offers authors online “open access” publishing for supposed more and quicker exposure, for a price: “Fees range between $500 and $5,000 US Dollars depending on the journal”.
And Elsevier too is responsible for the explosive growth in numbers of journals. In 1991, Elsevier took over the prestigious British journal THE LANCET. But prestige alone evidently doesn’t bring in enough money, so Elsevier has traded on The Lancet brand to proliferate publications: The Lancet Oncology since 2000, The Lancet Infectious Diseases since 2001, The Lancet Neurology since 2002; in 2013 were added The Lancet Diabetes & Endocrinology, The Lancet Global Health, and The Lancet Respiratory Medicine; in 2014, The Lancet HIV.

Posted in HIV skepticism, prejudice, uncritical media | Tagged: , , | Leave a Comment »

 
Follow

Get every new post delivered to your Inbox.

Join 120 other followers